Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against ...

A new nasal spray blocks and neutralizes almost 100% ... protection against various respiratory infections, including COVID-19, influenza, common cold viruses, and bacteria that cause pneumonia.

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract allows for robust antibody and T-cell responses where SARS-CoV-2 generally ...

On March 10, the Department of Justice (DOJ) moved to drop a lawsuit filed on behalf of the Federal Trade Commission (FTC) against Xlear, ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic reactions in patients who weigh between 15 and 30 kilograms, the company said on ...

A recent study has found an over-the-counter nasal spray may interfere with respiratory virus diagnostic swabs. Northern ...